TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12888362

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study: 15602800

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS) 40 microg t.i.d. for 3 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluindione 20 mg
Number of subjects: 12
Study: 8688266

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 23

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 23
Study: 1848268

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg orally twice daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Amphotericin B (0.6 mg/kg daily or 0.3 mg/kg in combination with flucytosine)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 32

Group type: COMPARATOR
Intervention: Amphotericin B
Number of subjects: 32
Study: 6676676

Group type: EXPERIMENTAL
Intervention: Carbamazepine 100 mg/day for 8 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for 8 days
Number of subjects: 32
Study: 30868612

Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 80
Study: 29915123

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13299

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 13299
Study: 26825975

Group type: EXPERIMENTAL
Intervention: Readiness Group (RG) with incentives
Number of subjects: 75

Group type: COMPARATOR
Intervention: Readiness Group (RG) without incentives
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Readiness Group (RG)
Number of subjects: 75
Study: 24325851

Group type: EXPERIMENTAL
Intervention: Informative feedback after each response during training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-informative feedback during training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Informative feedback
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-informative feedback
Number of subjects: 24
Study: 25083241

Group type: EXPERIMENTAL
Intervention: Night-time dosing of thiazide diuretics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morning dosing of thiazide diuretics
Number of subjects: 0
Study: 21036118

Group type: EXPERIMENTAL
Intervention: Training Group (TG) - additional physical exercises for 4 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control Group (CG) - conventional rehabilitation for 4 weeks
Number of subjects: 18
Study: 17166315

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation program
Number of subjects: 0
Study: 16281091

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) treatment
Number of subjects: 6
Study: 11873000

Group type: EXPERIMENTAL
Intervention: Ritonavir (RTV) 400 mg and Saquinavir soft-gel (SQVsgc) 400 mg twice daily with Pravastatin 40 mg daily (arm 1)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ritonavir (RTV) 400 mg and Saquinavir soft-gel (SQVsgc) 400 mg twice daily with Simvastatin 40 mg daily (arm 2)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ritonavir (RTV) 400 mg and Saquinavir soft-gel (SQVsgc) 400 mg twice daily with Atorvastatin 40 mg daily (arm 3)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Nelfinavir (NFV) 1250 mg twice daily with Pravastatin 40 mg daily (arm 4)
Number of subjects: 56
Study: 10468065

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (Lng-IUS)
Number of subjects: 82
Study: 8675718

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guided mastery therapy
Number of subjects: 0
Study: 1282585

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 4058186

Group type: EXPERIMENTAL
Intervention: Synchronous abdominoperineal rectum excision
Number of subjects: 421

Group type: COMPARATOR
Intervention: Metachronous abdominoperineal rectum excision
Number of subjects: 421
Study: 31254522

Group type: EXPERIMENTAL
Intervention: Onabotulinumtoxin A (200 units)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (20 mL saline)
Number of subjects: 59
Study: 29215517

Group type: EXPERIMENTAL
Intervention: Midurethral sling
Number of subjects: 113

Group type: COMPARATOR
Intervention: Burch retropubic urethropexy
Number of subjects: 113
Study: 26026818

Group type: EXPERIMENTAL
Intervention: Unithermia(®) with MMC-C and hyperthermia (HT)
Number of subjects: 34
Study: 25631970

Group type: EXPERIMENTAL
Intervention: 50 mg of ferrous sulfate twice a week for 16 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study: 22921641

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 320

Group type: COMPARATOR
Intervention: Attention control successful aging condition
Number of subjects: 320
Study: 19782353

Group type: EXPERIMENTAL
Intervention: Single preovulatory intrauterine insemination (IUI) performed 24 hours after hCG administration
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Two IUIs performed 12 and 36 hours after hCG administration
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Single periovulatory IUI performed 36 hours after hCG administration
Number of subjects: 450
Study: 18585494

Group type: EXPERIMENTAL
Intervention: Full prescription drug coverage (no copays, coinsurance, or deductibles) for statins, beta-blockers, ACE inhibitors, and angiotensin II receptor blockers.
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Current levels of pharmacy benefit (control group).
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Full prescription drug coverage (no copays, coinsurance, or deductibles).
Number of subjects: 1000
Study: 15742336

Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic stem cell transplantation (allo‐HSCT)
Number of subjects: 0
Study: 12042291

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 229

Group type: COMPARATOR
Intervention: Surgical management
Number of subjects: 229

Group type: COMPARATOR
Intervention: Preference-based management (both expectant and surgical)
Number of subjects: 229
Study: 9180668

Group type: EXPERIMENTAL
Intervention: Intervention unit (n = 326)
Number of subjects: 650

Group type: COMPARATOR
Intervention: Usual care (n = 324)
Number of subjects: 650
Study: 7609511

Group type: EXPERIMENTAL
Intervention: Calcium-channel blockers
Number of subjects: 0
Study: 2884879

Group type: EXPERIMENTAL
Intervention: SMS 201-995 (25 micrograms, subcutaneously, twice daily)
Number of subjects: 0
Study: 29261533

Group type: EXPERIMENTAL
Intervention: Triamcinolone (KA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hyaluronate (HA)
Number of subjects: 30
Study: 26947331

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus palbociclib
Number of subjects: 521

Group type: COMPARATOR
Intervention: Fulvestrant plus placebo
Number of subjects: 521
Study: 25194408

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (250 mg, three times per week for 8 weeks)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo injection (saline)
Number of subjects: 172

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 172
Study: 21478298

Group type: EXPERIMENTAL
Intervention: Damon™ 3 self‐ligating brackets (SLB)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Mini Diamond conventional ligating brackets (CLB)
Number of subjects: 29
Study: 20105426

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 18082217

Group type: EXPERIMENTAL
Intervention: Prostataplex soft gels (2 soft gels daily for 12 weeks)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo soft gels (2 soft gels daily for 12 weeks)
Number of subjects: 92
Study: 16632780

Group type: EXPERIMENTAL
Intervention: Doppler sonography in patients with colorectal liver metastases
Number of subjects: 28
Study: 14705281

Group type: EXPERIMENTAL
Intervention: Intensive academic detailing for general practitioners (GPs)
Number of subjects: 39
Study: 11037850

Group type: EXPERIMENTAL
Intervention: Oral cloxacillin and cefixime
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 8610379

Group type: EXPERIMENTAL
Intervention: BT563 (10 mg/day for 12 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: ATG (5 mg/kg/day for 7 days)
Number of subjects: 60
Study: 8240460

Group type: EXPERIMENTAL
Intervention: Oral administration of 2 mg E2
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral administration of 4 mg E2
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral administration of 8 mg E2
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 0.3 mg E2
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral administration of E2 (overall)
Number of subjects: 14
Study: 3486756

Group type: EXPERIMENTAL
Intervention: Single dose (SD) of 2 mg/kg intravenously
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Single dose (SD) of 2 mg/kg plus a 2 mg/kg/h intravenous infusion (SDI)
Number of subjects: 24
Study: 30080889

Group type: EXPERIMENTAL
Intervention: Music listening
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: News listening
Number of subjects: 50

Group type: COMPARATOR
Intervention: No sound (control)
Number of subjects: 50
Study: 26905956

Group type: EXPERIMENTAL
Intervention: Peer co-led educational programme (8-hour group session + individual pretreatment planning session)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Peer co-led educational programme
Number of subjects: 93
Study: 24434128

Group type: EXPERIMENTAL
Intervention: Pulsatile Electrostatic Field (PESF) treatment in group C (T2DM with leg ulcers)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pulsatile Electrostatic Field (PESF) treatment in group A (obese without glucose intolerance)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pulsatile Electrostatic Field (PESF) treatment in group B (obese intolerant to glucose)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group D (T2DM with leg ulcers)
Number of subjects: 67
Study: 22374991

Group type: EXPERIMENTAL
Intervention: Diffuse gastric cancer incidence among foreign-born Hispanic men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diffuse gastric cancer incidence among U.S.-born Hispanic women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intestinal gastric cancer incidence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardia and noncardia gastric cancer incidence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncardia and both intestinal and diffuse gastric cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardia tumors incidence among younger and middle-aged Hispanic men
Number of subjects: 0
Study: 20439601

Group type: EXPERIMENTAL
Intervention: Prophylactic surfactant
Number of subjects: 208

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 208
Study: 18328683

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol (FSC(BHR) group)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP(BHR) group)
Number of subjects: 466

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP(REF) group)
Number of subjects: 466
Study: 15620775

Group type: EXPERIMENTAL
Intervention: Anterior approach (n=81)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Posterior approach (n=46)
Number of subjects: 127
Study: 12091559

Group type: EXPERIMENTAL
Intervention: Reactive recovery response to the first slip
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Repeated exposure to slip perturbation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Knowledge of surface condition before hand
Number of subjects: 12
Study: 10361180

Group type: EXPERIMENTAL
Intervention: Fundic mobilization during Nissen fundoplication
Number of subjects: 50

Group type: COMPARATOR
Intervention: No fundic mobilization during Nissen fundoplication
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fundic mobilization
Number of subjects: 50

Group type: COMPARATOR
Intervention: No fundic mobilization
Number of subjects: 50
Study: 8636011

Group type: EXPERIMENTAL
Intervention: Paclitaxel 240 mg/m2
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Paclitaxel 270 mg/m2
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Paclitaxel 3-h infusion
Number of subjects: 27
Study: 2167727

Group type: EXPERIMENTAL
Intervention: Intralesional interferon alpha‐2b (Intron a)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 381955

Group type: EXPERIMENTAL
Intervention: Ticrynafen, 125‐‐250 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Probenecid, 0.5‐‐1.0 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ticrynafen
Number of subjects: 0
Study: 31926442

Group type: EXPERIMENTAL
Intervention: Eye movements during memory recall
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control condition (no eye movements)
Number of subjects: 140
Study: 31388297

Group type: EXPERIMENTAL
Intervention: Subthreshold depression (HADS depression score 4-7)
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: HADS depression >8
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Depression (general)
Number of subjects: 355
Study: 28551283

Group type: EXPERIMENTAL
Intervention: 30mg of dexamethasone i.v. and i.m.
Number of subjects: 119

Group type: COMPARATOR
Intervention: No glucocorticoid (control)
Number of subjects: 119
Study: 25033745

Group type: EXPERIMENTAL
Intervention: Warmed irrigation solutions (37 °C) in group W
Number of subjects: 60

Group type: COMPARATOR
Intervention: Room temperature irrigation solutions (21 °C) in group R
Number of subjects: 60
Study: 23281623

Group type: EXPERIMENTAL
Intervention: Tool for Evaluating Research Implementation Challenges (TECH)
Number of subjects: 8
Study: 21964530

Group type: EXPERIMENTAL
Intervention: COX-2 or 5-LOX inhibitors plus chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 0
Study: 18205578

Group type: EXPERIMENTAL
Intervention: Combined chlamydia and Pap screening offered by doctors in intervention practices
Number of subjects: 26876

Group type: COMPARATOR
Intervention: Usual practice (screening guidelines based on risk assessment) in control practices
Number of subjects: 26876

Group type: COMPARATOR
Intervention: Intervention practices compared to control practices
Number of subjects: 26876
Study: 16918897

Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14666026

Group type: COMPARATOR
Intervention: Conventional extracorporeal circulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Uncoated extracorporeal circulation with shed blood separation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Coated extracorporeal circulation with shed blood separation
Number of subjects: 40

Group type: COMPARATOR
Intervention: No extracorporeal circulation
Number of subjects: 40
Study: 10971533

Group type: EXPERIMENTAL
Intervention: Mucodyne
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 8655160

Group type: EXPERIMENTAL
Intervention: Azithromycin Regimen A - 1.0 g once weekly for 4 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Azithromycin Regimen B - 500 mg daily for 7 days
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Azithromycin (both regimens)
Number of subjects: 11
Study: 1513195

Group type: EXPERIMENTAL
Intervention: Propofol infusion (mean total dose 6.4 +/- 2.7 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoflurane (mean concentration 0.9 +/- 0.4%)
Number of subjects: 40
Study: 6440180

Group type: EXPERIMENTAL
Intervention: Diazepam 2.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31399943

Group type: EXPERIMENTAL
Intervention: Preoperative intragastric balloon (IGB)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (no IGB)
Number of subjects: 66
Study: 29368178

Group type: EXPERIMENTAL
Intervention: CT-based virtual surgical planning with 3D printed pre-contoured plates (Group A)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional method of intra-operative contouring (Group B)
Number of subjects: 25
Study: 26644265

Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Text4Diet
Number of subjects: 20
Study: 25787196

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 280
Study: 23086179

Group type: EXPERIMENTAL
Intervention: Cerebellar lesions
Number of subjects: 47

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 47
Study: 21108021

Group type: EXPERIMENTAL
Intervention: Silastic® ring sleeve gastrectomy (SRSG)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Silastic® ring gastric bypass (SRGB)
Number of subjects: 65
Study: 18476293

Group type: EXPERIMENTAL
Intervention: Drug Conservation (DC)
Number of subjects: 5472

Group type: COMPARATOR
Intervention: Viral Suppression (VS)
Number of subjects: 5472

Group type: EXPERIMENTAL
Intervention: DC with CD4+ cell count <350 cells/microL
Number of subjects: 5472

Group type: EXPERIMENTAL
Intervention: DC with CD4+ cell count >=350 cells/microL
Number of subjects: 5472
Study: 16571140

Group type: EXPERIMENTAL
Intervention: Recombinant Hepatitis B virus vaccine (40 microg for HIV positive patients, 20 microg for controls)
Number of subjects: 60
Study: 13679330

Group type: EXPERIMENTAL
Intervention: Ultrasonographic screening for AAA
Number of subjects: 125000
Study: 10736382

Group type: EXPERIMENTAL
Intervention: Monosodium glutamate (MSG) given without food
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 8624183

Group type: EXPERIMENTAL
Intervention: 8 mg/d of buprenorphine
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: 30 mg/d of methadone
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: 80 mg/d of methadone
Number of subjects: 225

Group type: COMPARATOR
Intervention: low-dose methadone
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: high-dose methadone
Number of subjects: 225
Study: 1308919

Group type: EXPERIMENTAL
Intervention: Single Energy Quantitative Computed Tomography (SEQCT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dual Energy X‐ray Absorptiometry (DEXA)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Total Body DEXA
Number of subjects: 44
Study: 2578493

Group type: EXPERIMENTAL
Intervention: Oral hydroxyzine, 25 mg four times a day
Number of subjects: 0
Study: 31411985

Group type: EXPERIMENTAL
Intervention: Docetaxel + ADT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abiraterone + ADT
Number of subjects: 0

Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 0
Study: 29663828

Group type: EXPERIMENTAL
Intervention: Nurse-led palliative care intervention integrated with anti-retroviral therapy (ART)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 26392403

Group type: EXPERIMENTAL
Intervention: Melt-in-mouth pellets of taste-masked atomoxetine hydrochloride
Number of subjects: 10
Study: 24656538

Group type: EXPERIMENTAL
Intervention: Cangrelor infusion (bolus plus 2-h infusion) and ticagrelor (180 mg) at 0.5 h (n = 6) or 1.25 h (n = 6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg twice daily for either 6 doses or 7 doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ticagrelor given before or during infusion of cangrelor
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ticagrelor during infusion of cangrelor
Number of subjects: 12
Study: 22747914

Group type: EXPERIMENTAL
Intervention: Benefit finding intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simplified psychoeducation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 20920649

Group type: EXPERIMENTAL
Intervention: Low-power 808-nm laser illumination
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no laser illumination)
Number of subjects: 101
Study: 18597667

Group type: EXPERIMENTAL
Intervention: Problem-based learning methodology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional teaching methods (implied control)
Number of subjects: 0
Study: 16651318

Group type: EXPERIMENTAL
Intervention: ECMO
Number of subjects: 185

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 185
Study: 12756156

Group type: EXPERIMENTAL
Intervention: POTS patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 25
Study: 10817002

Group type: EXPERIMENTAL
Intervention: Unilateral spinal anesthesia with 8 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Combined sciatic-femoral nerve block with 25 ml of 2% mepivacaine
Number of subjects: 50
Study: 8685662

Group type: EXPERIMENTAL
Intervention: Individualized consultation
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Group psychoeducation
Number of subjects: 183

Group type: COMPARATOR
Intervention: Wait list
Number of subjects: 183
Study: 1724365

Group type: EXPERIMENTAL
Intervention: Aprotinin (Trasylol)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6841658

Group type: EXPERIMENTAL
Intervention: Deltoid morphine (8 and 16 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Deltoid methadone (10 mg)
Number of subjects: 32
Study: 31332803

Group type: EXPERIMENTAL
Intervention: Workplace bullying
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Perceived burdensomeness
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Thwarted belongingness
Number of subjects: 471
Study: 29152781

Group type: EXPERIMENTAL
Intervention: Glecaprevir and pibrentasvir (G/P; 300 mg/120 mg) for 12 weeks
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Glecaprevir and pibrentasvir (G/P; 300 mg/120 mg) for 16 weeks
Number of subjects: 91
Study: 27819111

Group type: EXPERIMENTAL
Intervention: Loop diuretics (including doses ≥80 mg furosemide equivalent/day)
Number of subjects: 1190

Group type: COMPARATOR
Intervention: No loop diuretics
Number of subjects: 1190